<DOC>
	<DOCNO>NCT00005120</DOCNO>
	<brief_summary>The purpose study see safe effective give calanolide A HIV-infected adult use anti-HIV drug past .</brief_summary>
	<brief_title>The Safety Effectiveness ( + ) -Calanolide A HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs</brief_title>
	<detailed_description>Patients randomize receive ( + ) -calanolide A placebo 21 day . All patient may elect receive open-label , 3-month course approve retroviral therapy ( triple-drug therapy ) select , administer care , patient ' physician . If patient insurance coverage wish utilize his/her insurance anti-HIV medication , Sarawak MediChem Pharmaceuticals provide medication charge 3 month .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Calanolide A</mesh_term>
	<criteria>Inclusion Criteria Patients may eligible study : Are least 18 year old . Agree use effective method birth control study . Have CD4 cell count 200 cells/mm3 . Have HIV level 5000 copies/ml . Exclusion Criteria Patients eligible study : Have abnormal blood test . Have reaction study medication . Have history opportunistic ( AIDSrelated ) infection cancer . Are treat active pulmonary tuberculosis . Have fever 39 degree C within 14 day begin study treatment . Are unable take medication mouth . Have abnormal chest Xray ECG within 30 day begin study treatment . Have hepatitis , hemophilia , blood disorder . Have significant heart , stomach , intestinal , liver , nerve , kidney problem . Have condition may affect ability participate study , drug alcohol abuse serious mental disorder . Have take antiHIV drug past . Are take certain medication . Have blood transfusion within 3 month prior enter study . Have radiation chemotherapy within 16 day screen visit plan receive treatment study . Are pregnant breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2001</verification_date>
	<keyword>CD4 Lymphocyte Count</keyword>
	<keyword>Biological Markers</keyword>
	<keyword>Anti-HIV Agents</keyword>
	<keyword>Viral Load</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>calanolide A</keyword>
</DOC>